Piper Jaffray Downgrades Vascular Solutions (VASC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street ends down sharply, worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Vertiv shares fall on analyst downgrades and options bets
- Stocks slip as dollar heads for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
Jefferies Raises Price Target on Teleflex (TFX) Ahead of Vascular Solutions (VASC) Acquisition
December 5, 2016 8:05 AM ESTJefferies reiterated a Hold rating on Teleflex (NYSE: TFX), and raised the price target to $155.00 (from $154.00) ahead of the company's acquisition of Vascular Solutions (NASDAQ: VASC) for $56 per share. Vascular Solutions will be both growth and margin accretive... More
Teleflex (TFX) to Acquire Vascular Solutions (VASC) in $1B Deal
December 2, 2016 6:47 AM ESTVascular Solutions, Inc. (Nasdaq: VASC) announced that it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56.00 per share in cash. The transaction implies an equity purchase price of $1.0 billion. Upon completion of the transaction, Vascular Solutions will become a wholly owned subsidiary of Teleflex.
The purchase price represents a 16% premium over Vascular Solutions average closing price during the 90 trading days ended December 1, 2016. In addition, the purchase price is 38.4x the midpoint of the companys preliminary 2017... More



